Try Alerts Free   |   Login

LFST Price Correlated With Financials For LifeStance Health

Free historical financial statements for LifeStance Health Group Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 4 quarters since 2021. Compare with LFST stock chart to see long term trends.

LFST Stock Compared to Quarterly

LFST Income Statement

Revenue, Net:203095000
Revenue Per Share:0.5426
Selling, General & Admin Expense:103369000
Total Operating Expenses:267946000
Operating Income:-69004000
Income Taxes:-6676000
Net Income:-62328000
Earnings Per Share, Basic:-0.18
Shares Outstanding, Basic Avg:374323422

LFST Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:15684000
Change in Accounts Receiveable:18121000
Net Cash from Operations:3308000
Net Cash from Operations Per Share:0.0088
Issuance of Long-term Debt:20000000
Net Cash from Financing Activities:13508000
Property, Plant & Equipment Purchases:27910000
Purchases of Businesses, Net of Cash:22945000
Net Cash from Investing Activities:-50855000
Net Change in Cash & Equivalents:-34039000

LFST Balance Sheet

Cash and Cash Equivalents:113990000
Accounts Receivable, Net:94991000
Total Current Assets:263297000
Property, Plant & Equipment, Net:170927000
Total Assets:1958386000
Accounts Payable:15136000
Current Portion of Long-Term Debt:1323000
Total Short-Term Liabilities:125597000
Long Term Debt, Non-Current Portion:177380000
Total Liabilities:415868000
NOTE 1 NATURE OF THE BUSINESS Description of Business LifeStance Health Group, Inc. (“LifeStance Health Group”) was formed as a Delaware corporation on January 28, 2021 for the purpose of completing an initial public offering (“IPO”) and related transactions in order to carry on the business of LifeStance TopCo, L.P. (“LifeStance TopCo”) and subsidiaries. LifeStance Health Group is the sole equity holder of LifeStance TopCo and operates and controls all of the business and affairs. As a result, LifeStance Health Group consolidates the financial results of LifeStance TopCo, its wholly-owned subsidiaries and variable interest entities. LifeStance Health Group and LifeStance TopCo are collectively referred to herein as the “Company”, "LifeStance" or "LifeStance Health". The Company operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. Initial Public Offering On June 14, 2021, the Company completed its IPO in which it issued and sold 32,800 shares of common stock and affiliates of TPG Inc. ("TPG"), affiliates of Silversmith Capital Partners ("Silversmith"), and affiliates of Summit Partners ("Summit") (collectively, the "Selling Shareholders") sold 7,200 shares of common stock at an offering price of $ 18.00 per share. The Selling Shareholders granted the underwriters an option to purchase an additional 6,000 shares of common stock. The underwriters exercised in full their option to purchase additional shares, and the sale of the option shares was completed on June 25, 2021. The Company received net proceeds of $ 548,905 , after deducting underwriting discounts and commissions of $ 32,472 and deferred offering costs of $ 9,023 . The Company did not receive any proceeds from the sale of shares by the Selling Stockholders, including the option shares. Deferred, direct offering costs were capitalized and consisted of fees and expenses incurred in connection with the sale of the Company’s common stock in the IPO, including legal, accounting, printing and other offering related costs. Upon completion of the IPO, these deferred offering costs were reclassified from current assets to stockholders’ equity and recorded against the net proceeds from the offering. Prior to the IPO, each of the holders of partnership interests in LifeStance TopCo contributed its partnership interests to LifeStance Health Group in exchange for shares of common stock (including shares of common stock issued as restricted stock subject to vesting) of LifeStance Health Group (the "Organizational Transactions"). Following the contribution of partnership interests, LifeStance TopCo became wholly-owned by LifeStance Health Group. The number of shares of common stock that each such holder of partnership interests in LifeStance TopCo received was determined based on the value that such holder would have received under the distribution provisions of the limited partnership agreement of LifeStance TopCo, with shares of common stock valued by reference to the IPO price. All 1,046,196 of LifeStance TopCo’s outstanding redeemable and common Class A units and 152,620 Class B units (the "Class B Common Units", "Profits Interests Units" or "Profits Interests") were contributed in exchange for 310,083 shares of common stock of LifeStance Health Group plus 30,766 shares of common stock issued as restricted stock ("RSAs") subject to vesting. In connection with the IPO, the Company established the LifeStance Health Foundation, a non-profit organization that focuses on youth mental health, and the mental health of underrepresented minority communities, the underemployed and the uninsured. Concurrently with the closing of the IPO, the Company endowed the LifeStance Health Foundation through a combination of $ 1,000 in cash and 500 shares of its common stock, representing aggregate cash and equity value of $ 10,000 . Following the effective d

Data imported from LifeStance Health Group Inc. SEC filings. Check original filings before making any investment decision.